GS-621763
Product Specifications
CAS Number
2647442-13-3
Target
SARS-CoV
Applications
Microbiology
Smiles
CC (C) C (=O) OCC1OC (C#N) (C (OC (=O) C (C) C) C1OC (=O) C (C) C) C2=CC=C3[N]2N=CN=C3N
Molecular Formula
C24H31N5O7
Additionnal Information
GS-621763, an orally bioavailable prodrug of GS-441524, shows a dose-dependent antiviral effect on SARS-CoV-2 reporter virus expressing nanoluciferase (SARS-CoV-2 nLUC) replication with an EC50 of 2.8 μM, also inhibits reporter SARS-CoV-2 expressing firefly luciferase (SARS-CoV-2 Fluc) replication with EC50 of 0.125 μM.
Storage Conditions
3 years -20°C powder
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15401523 1 Vial
Lentiviral human DAPK2 sgRNA gene knockout kit - Lentiviral human DAPK2 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details 
031518-ML490 100 µL
ACAD8, ID (ACAD8, ARC42, IBD, Isobutyryl-CoA dehydrogenase, mitochondrial, Activator-recruited cofactor 42kD component, Acyl-CoA dehydrogenase family member 8) (MaxLight 490) discontinued
Sign In for Pricing
View Details